Insider Transactions Reported by 23 Insiders of TriSalus Life Sciences, Inc.

Symbol
TLSI, TLSIW on Nasdaq
Location
Westminster, CO

Insiders trading volume in the past year

TriSalus Life Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
MedTech Acquisition Sponsor LLC 10%+ Owner $65,538,115 26 Jun 2023
Frankenius Equity AB 10%+ Owner $24,736,070 10 Feb 2025
Mats Wahlstrom Director $10,580,852 12 Jun 2025
Sean Murphy Director $3,818,390 +$157,200 +4.3% 12 Jun 2025
DAVID J. MATLIN Director $3,739,518 12 Jun 2025
Mary T. Szela CEO AND PRESIDENT, Director $3,520,881 +$102,057 +3% 18 Feb 2025
George Kelly Martin Director $1,359,468 28 Aug 2024
David Patience Chief Financial Officer $1,256,100 24 Nov 2025
Arjun JJ Desai Director $911,899 12 Jun 2025
Bryan F. Cox Chief of Research $789,679 -$24,678 -3% 24 Nov 2025
Jennifer Stevens Chief Regulatory Officer $605,013 -$45,087 -6.9% 24 Nov 2025
Richard Marshak Chief Commercial Officer $539,667 -$34,172 -6% 24 Nov 2025
James Alecxih President, Device Technology $521,147 10 Aug 2023
Jodi Devlin Chief of Clinical Operations $476,706 -$24,678 -4.9% 24 Nov 2025
James Emmett Young Chief Financial Officer $428,854 +$163,500 +62% 19 May 2025
Steven C. Katz Chief Medical Officer $377,229 12 Feb 2024
Magnetar Financial LLC 10%+ Owner $174,782 12 Jun 2023
Liselotte Hyveled Director $39,859 02 Jan 2025
William Valle Director 12 Jun 2025
Gary B. Gordon Director 12 Jun 2025
KERRY R. HICKS Director 12 Jun 2025
ANDREW C. VON ESCHENBACH Director 13 Aug 2024
Anil K. Singhal Director 13 Aug 2024

Recent Insider Transactions by Companies or Individuals for TriSalus Life Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.